ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 198,696 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 6976 to 6999 of 8600 messages
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older
DateSubjectAuthorDiscuss
26/8/2020
14:31
oioi.. rockets getting wheeled out to launchpad

Breaking out n ready to test 20

Thanks y’all

rocket fuel
26/8/2020
09:25
Expect to see the usual big buys hidden from view for an hour or two;)
ch1rp
26/8/2020
07:57
For your information Nobb no vaccine nor silica based delivery system ever has. That's the point of medical trials:)News due anytime now on the agglomeration study results. This is a potential changer as upon success means nuvec has a much better chance of being effective using only one injection. Plus people forgetting Evotec started additional in vitro studies a couple of months ago to investigate if nuvec can transfect both murine intestinal cells and also human gastrointestinal mucosal/epithelial cells. This is key to assessing if the oral application route is feasible or not. Results could come any time. Updates also due on on viral vector manufacturing & partnership news.
ch1rp
26/8/2020
07:37
It has never been in a human so how do they know it's great at delivering RNA. It's easy to do such experiments in inbred animal strains but ever so slightly different in outbred humans.

The proof of the pudding is in the eating and this pudding hasn't even gone in the oven yet.....

nobbygnome
26/8/2020
07:29
Love this post from Dangil on lseCOVID VaccineTue 16:19great piece by proactive https://www.proactiveinvestors.co.uk/companies/news/927503/the-runners-in-the-covid-19-vaccine-race-927503.html.Great news for us some of these use RNA based inoculation which requires a delivery system and here comes Nuvec which has proven to be great at. buy buy buy
ch1rp
26/8/2020
07:10
RedFlags everywhere
andymunchkin
26/8/2020
07:09
PumpIs over exRampingCnts rDumping
andymunchkin
25/8/2020
09:48
Whilst nothing goes up in a straight line, all of this is part of the general breakout to 16p happening right now. Great day yesterday. 12p base will be formed this week imo :)))
ch1rp
24/8/2020
15:53
A good size buy now 79K, if it follows with another one the level 2 will be back as the high of the day
master rsi
24/8/2020
14:44
Something a foot lads I reckons gla
jimbob999
24/8/2020
14:41
Easy does it.
jibba jabber
24/8/2020
13:45
3 MMs moving up and with that the share price also
12.25 v 12.75p
1 v 1

already up again
has done to 3 v 4 at 12.25 v 13p

master rsi
24/8/2020
13:38
Something leaked? Getting very heavy and 13p is about to go. Next on the chart is 18p.
genierub
24/8/2020
10:04
Patience nobby it will happen.
charlie8888
24/8/2020
10:01
Pushing that upper boundary again. Pop coming.
hodhasharon
24/8/2020
10:01
Positive news coming on stage 3.
letmepass
24/8/2020
09:51
And how long before it actually goes into a human?

All they have used so far is animals, cell lines and proteins such as ovalbumin. All this is of very limited relevance for in vivo use in an outbred human population!

nobbygnome
24/8/2020
09:31
Not really. Just expecting a steady rise each week into news flows:Courtesy of John077 lseThose in vivo studies went ahead and the results were rns'ed 20/08/19. The results were very promising using both 2 &3 injections. They have since decided that a more monodisperse solution (all particles of a similar size) will result in less agglomeration (particles sticking together) and would make it much more likely to get better In vivo results using only one injection. The dispersion / agglomeration works have been ongoing and should be completed very soon. All looking good.From 06/07 rns it looks like the investigations into the oral applications are currently at the in-vitro phase Maz:'To that end the Company will working with Evotec to undertake some preliminary in vitro studies to establish first that Nuvec® can be optimised to transfect murine intestinal cells and, secondly, that it can transfect human gastrointestinal mucosal/epithelial cells. Without being able to efficiently transfect gut cells, any oral application would not be possible, so it is essential to complete these studies prior to progressing any further with this initiative.'Assuming this study was started immediately, we could be approx 45 days into these works so news could come at any time on this.Also awaiting further updates on:viral vector manufacturing the pre in-vivo studyDispersion / agglomeration worksOngoing potential commercial partner discussionsAll the above have the potential to be transformational....Great time to be in here.
ch1rp
24/8/2020
09:24
Is your crystal ball in for repairs?
dplewis1
24/8/2020
09:22
Level 2

2 at 12p bid now

master rsi
24/8/2020
08:54
Are you expecting news this week?
hodhasharon
24/8/2020
08:43
Level 2 improving all the time, and many MMs have move +0.375 (3.19%)

currently 2 at 11.75
and offer went from 12 to 12.50p now

master rsi
23/8/2020
11:41
La la la.... blissfully unaware of all your troll arguments from now on. What a relief! Looking forward to news on all fronts:Courtesy of John077 lseThose in vivo studies went ahead and the results were rns'ed 20/08/19. The results were very promising using both 2 &3 injections. They have since decided that a more monodisperse solution (all particles of a similar size) will result in less agglomeration (particles sticking together) and would make it much more likely to get better In vivo results using only one injection. The dispersion / agglomeration works have been ongoing and should be completed very soon. All looking good.From 06/07 rns it looks like the investigations into the oral applications are currently at the in-vitro phase Maz:'To that end the Company will working with Evotec to undertake some preliminary in vitro studies to establish first that Nuvec® can be optimised to transfect murine intestinal cells and, secondly, that it can transfect human gastrointestinal mucosal/epithelial cells. Without being able to efficiently transfect gut cells, any oral application would not be possible, so it is essential to complete these studies prior to progressing any further with this initiative.'Assuming this study was started immediately, we could be approx 45 days into these works so news could come at any time on this.Also awaiting further updates on:viral vector manufacturing the pre in-vivo studyDispersion / agglomeration worksOngoing potential commercial partner discussionsAll the above have the potential to be transformational....Great time to be in here.
ch1rp
23/8/2020
11:26
Lol ok if you can't deal with facts just ignore them
dplewis1
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older

Your Recent History

Delayed Upgrade Clock